File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Remifentanil Preconditioning Attenuates Hepatic Ischemia-Reperfusion Injury in Rats via Neuronal Activation in Dorsal Vagal Complex

TitleRemifentanil Preconditioning Attenuates Hepatic Ischemia-Reperfusion Injury in Rats via Neuronal Activation in Dorsal Vagal Complex
Authors
Keywordsalanine aminotransferase blood level
aminotransferase blood level
animal cell
animal experiment
animal model
Issue Date2018
PublisherHindawi Publishing Corporation. The Journal's web site is located at http://www.hindawi.com/journals/mi/index.html
Citation
Mediators of Inflammation, 2018, v. 2018, p. article no. 3260256 How to Cite?
AbstractRemifentanil, an ultra-short acting opiate, has been reported to protect against hepatic ischemia-reperfusion injury, which is a major cause of postoperative liver dysfunction. The objective of this study was to determine whether a central vagal pathway is involved in this protective procedure. Rat models of hepatic ischemia-reperfusion were used in the experimental procedures. The results revealed that intravenous pretreatment with remifentanil decreased serum aminotransferases and hepatic histologic damage; however, an intraperitoneal injection of μ-opioid receptor antagonist did not abolish the protection of remifentanil preconditioning. c-Fos immunofluorescence of the brain stem showed that dorsal motor nucleus of the vagus was activated after remifentanil preconditioning. Moreover, serum alanine aminotransferase, histopathologic damage, and apoptosis decreased in remifentanil preconditioning group compared to vagotomized animals with remifentanil preconditioning, and there was no statistical difference of TNF-α and IL-6 between NS/Va and RPC/Va groups. In addition, remifentanil microinjection into dorsal vagal complex decreased serum aminotransferases, inflammatory cytokines, and hepatic histologic injury and apoptosis, and these effects were also abolished by a peripheral hepatic vagotomy. In conclusion, remifentanil preconditioning conferred liver protection against ischemia-reperfusion injury, which was mediated by the central vagal pathway.
Persistent Identifierhttp://hdl.handle.net/10722/283711
ISSN
2019 Impact Factor: 3.758
2015 SCImago Journal Rankings: 1.370
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorCui, C-
dc.contributor.authorYu, F-
dc.contributor.authorY, S-
dc.contributor.authorYang, YT-
dc.contributor.authorJiao, YF-
dc.contributor.authorCheung, CW-
dc.contributor.authorWang, X-
dc.contributor.authorQI, B-
dc.contributor.authorLiu, Y-
dc.contributor.authorLi, P-
dc.contributor.authorYu, W-
dc.contributor.authorXiao, J-
dc.contributor.authorYang, L-
dc.date.accessioned2020-07-03T08:23:03Z-
dc.date.available2020-07-03T08:23:03Z-
dc.date.issued2018-
dc.identifier.citationMediators of Inflammation, 2018, v. 2018, p. article no. 3260256-
dc.identifier.issn0962-9351-
dc.identifier.urihttp://hdl.handle.net/10722/283711-
dc.description.abstractRemifentanil, an ultra-short acting opiate, has been reported to protect against hepatic ischemia-reperfusion injury, which is a major cause of postoperative liver dysfunction. The objective of this study was to determine whether a central vagal pathway is involved in this protective procedure. Rat models of hepatic ischemia-reperfusion were used in the experimental procedures. The results revealed that intravenous pretreatment with remifentanil decreased serum aminotransferases and hepatic histologic damage; however, an intraperitoneal injection of μ-opioid receptor antagonist did not abolish the protection of remifentanil preconditioning. c-Fos immunofluorescence of the brain stem showed that dorsal motor nucleus of the vagus was activated after remifentanil preconditioning. Moreover, serum alanine aminotransferase, histopathologic damage, and apoptosis decreased in remifentanil preconditioning group compared to vagotomized animals with remifentanil preconditioning, and there was no statistical difference of TNF-α and IL-6 between NS/Va and RPC/Va groups. In addition, remifentanil microinjection into dorsal vagal complex decreased serum aminotransferases, inflammatory cytokines, and hepatic histologic injury and apoptosis, and these effects were also abolished by a peripheral hepatic vagotomy. In conclusion, remifentanil preconditioning conferred liver protection against ischemia-reperfusion injury, which was mediated by the central vagal pathway.-
dc.languageeng-
dc.publisherHindawi Publishing Corporation. The Journal's web site is located at http://www.hindawi.com/journals/mi/index.html-
dc.relation.ispartofMediators of Inflammation-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectalanine aminotransferase blood level-
dc.subjectaminotransferase blood level-
dc.subjectanimal cell-
dc.subjectanimal experiment-
dc.subjectanimal model-
dc.titleRemifentanil Preconditioning Attenuates Hepatic Ischemia-Reperfusion Injury in Rats via Neuronal Activation in Dorsal Vagal Complex-
dc.typeArticle-
dc.identifier.emailCheung, CW: cheucw@hku.hk-
dc.identifier.emailWang, X: xmwang1@HKUCC-COM.hku.hk-
dc.identifier.authorityCheung, CW=rp00244-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1155/2018/3260256-
dc.identifier.pmid29861656-
dc.identifier.pmcidPMC5976991-
dc.identifier.scopuseid_2-s2.0-85055072724-
dc.identifier.hkuros310794-
dc.identifier.volume2018-
dc.identifier.spagearticle no. 3260256-
dc.identifier.epagearticle no. 3260256-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats